2024 U.S. Hospital Hemostasis Diagnostics Marke: Supplier Shares and Sales Segment Forecasts

July 2020 | 411 pages | ID: 2085DC09CB00EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com contains 411 pages, 28 tables. The report is available by section, and can be customized to specific information needs and budget. The report presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including:

• Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads.
• Review of current instrumentation technologies, and a feature comparison of leading analyzers.
• Reagent and instrument sales forecasts.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of coagulation technologies and their potential market applications.
• Major opportunities for new coagulation instruments and consumables.
• Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 411 pages and 28 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment 1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue-Type Plasminogen Activator (t-PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Molecular Diagnostics
  5. Microcomputers
  6. Automation
  7. Robotics
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

III. U.S.A.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

VI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics Market By Product Category
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
U.S.A., Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares